Announced

Completed

SK Group completed the acquisition of YpoKesi.

Synopsis

SK Group completed the acquisition of YpoKesi, a producer of gene and cell therapy products. Financial terms were not disclosed. "We are glad to advance into the gene therapy CMO business by investing in Yposkesi which has great capability and potential. We will spare no efforts to help Yposkesi grow fast in the global market," Jang Dong-Hyun, SK Group CEO.

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

All rights reserved. Copyright © 2025 Datasite

MergerLinks - SK Group completed the acquisition of YpoKesi.